期刊文献+

甲状腺功能五项量值溯源体系的建立与评价 被引量:3

An Establishment and Evaluation of Five-Analytes Thyroid Traceability System
下载PDF
导出
摘要 目的对甲状腺功能五项进行量值溯源研究,期望建立甲状腺功能五项量值溯源体系,以确保检测系统的检测结果准确可靠,为甲状腺功能五项检测标准化和一致化研究提供参考。方法按照GB/T 21415:2008(ISO 17511:2003)标准文件的规定对总三碘甲腺原氨酸(TT_(3))、总甲状腺素(TT_(4))、游离三碘甲腺原氨酸(FT_(3))、游离甲状腺素(FT_(4))、促甲状腺素(TSH)五项检测系统进行量值溯源,并通过国际参考实验室间质量评价(RELA)评价具有参考方法的TT_(3)和TT_(4)项目,通过国际参考品评价具有参考物质的TSH项目,通过方法学比对评价既无参考方法也无参考物质的FT_(3)和FT_(4)项目。结果迈克TT_(3)和TT_(4)项目溯源到JCTLM推荐的ID-LC/MS/MS参考方法,TSH项目溯源到有证参考物质NIBSC code:81/565,FT_(3)和FT_(4)项目通过方法学比对进行溯源,TT_(3)项目RELA样本A和RELA样本B的偏移分别为3.9%和2.5%,TT_(4)项目RELA样本A和RELA样本B的偏移分别为-0.2%和0.9%,偏移均较小。迈克系统测量TSH国际参考品高中低三个浓度水平的偏移分别是1.7%、0.8%和-3.9%,偏移均小于设定的最大允许误差(±10%)。FT_(3)项目罗氏系统与迈克系统临床比对结果的Passing-Bablok回归方程为Y=-0.403246+1.055337 X;相关系数r_(s)=0.95,可认为两者具有一致性。FT_(4)项目罗氏系统与迈克系统临床比对结果的Passing-Bablok回归方程为Y=-1.604055+1.087905 X;相关系数r_(s)=0.916,可认为两者具有一致性。结论建立了甲状腺功能五项量值溯源体系,量值溯源结果准确可靠。 Objective To conduct a research on the traceability of five analytes of thyroid.It is expected to establish a traceability system of five analytes of thyroid to ensure the accuracy and reliability of the detection system,and to provide a reference for the standardization and harmonization research of five analytes of thyroid.Methods According to GB/T 21415:2008(ISO 17511:2003)standard document,the quantitative traceability of the five-analytes detection systems of total triiodothylamine(TT_(3)),total thyroxine(TT_(4)),free triiodothylamine(FT_(3)),free thyroxine(FT_(4)),and thyrotropin(TSH)was carried out,and the TT_(3) and TT_(4) with reference methods were evaluated through the international reference laboratory quality assessment(RELA).TSH with reference materials were evaluated through international reference materials,FT_(3) and FT_(4) without reference methods or reference substances were evaluated through methodological comparison.Results TT_(3) and TT_(4) projects of Maccura were traced to the ID-LC/MS/MS reference method recommended by JCTLM,and TSH project was traced to the certified reference material NIBSC code:81/565.FT_(3) and FT_(4) projects were traced through methodological comparisons.The deviations of RELA sample A and RELA sample B of TT_(3) were 3.9%and 2.5%,respectively,and the deviations of RELA sample A and RELA sample B of TT_(4) were-0.2%and 0.9%,respectively,both of which were small.The deviations of TSH international reference at high,middle and low concentrations measured by Maccura system were 1.7%,0.8%and-3.9%,respectively,which were all less than the maximum allowable error(±10%)set.Passing-Bablok regression equation of clinical comparison results between Roche system and Maccura system in FT_(3) project was Y=-0.403246+1.055337X with correlation coefficient r_(s)=0.95,which was considered to be consistent.Passing-Bablok regression equation of clinical comparison results between Roche system and Maccura system in FT_(4) project was Y=-1.604055+1.087905X with correlation coefficient r_(s)=0.916,which was considered to be consistent.Conclusion A traceability system for five analytes of thyroid has been established,and the traceability results are accurate and reliable.
作者 鄢中华 顾心如 林晶晶 陆晓琴 杨思诚 孙可其 YAN Zhonghua;GU Xinru;LIN Jingjing;LU Xiaoqin;YANG Sicheng;SUN Keqi(Reference System Department of Maccura, Chengdu 611731, China)
出处 《标记免疫分析与临床》 CAS 2022年第1期170-173,180,共5页 Labeled Immunoassays and Clinical Medicine
基金 国家重点研发计划(编号:2019YFF016500)。
关键词 甲状腺功能五项 量值溯源 Five Analytes of Thyroid Traceability
  • 相关文献

参考文献4

二级参考文献91

  • 1刘俊峰,鞠萍.TSHIRMA测定对甲状腺功能的诊断价值[J].实用医技杂志,2006,13(14):2428-2429. 被引量:5
  • 2王晓熙,陈云,陆珍凤,周晓军,朱明华.甲状腺滤泡源性肿瘤Ret、Mucin-1和Galectin-3蛋白表达及临床病理分析[J].临床与实验病理学杂志,2006,22(5):625-626. 被引量:4
  • 3Myers GL,Kimberly MM,Waymack PP,et al.A reference method laboratory network for cholesterol:a model for standardization and improvement of clinical laboratory measurements[J].Clin Chem,2000,46(11):1762-1772.
  • 4New York State Proficiency Test Program.Oncology proficiency testing program-critiques&instructions[EB/OL].2011[2012-02-01].http://www.wad-sworth.org/labcert/clep/PT/oncology/serasoluble/index.htm.
  • 5Miller WG.Specimen materials,target values and commutability for external quality assessment(proficiency testing)schemes[J].Clin Chim Acta,2003,327(1-2):25-37.
  • 6Miller WG,Myers GL,Rej R.Why commutability matters[J].Clin Chem,2006,52(4):553-554.
  • 7Miller WG,Jones GR,Horowitz GL,et al.Proficiency testing/external quali-ty assessment:current challenges and future directions[J].Clin Chem,2011,57(12):1670-1680.
  • 8Blijenberg BG,Yurdakul G,Van Zelst BD,et al.Discordant performance of assays for free and total prostate-specific antigen in relation to the early detec-tion of prostate cancer[J].BJU international,2001,88(6):545-550.
  • 9Chan DW,Bruzek DJ,Oesterling JE,et al.Prostate-specific antigen as a marker for prostatic cancer:a monoclonal and a polyclonal immunoassay com-pared[J].Clin Chem,1987,33(10):1916-1920.
  • 10Davelaar EM,Van Kamp GJ,Verstraeten RA,et al.Comparison of seven immunoassays for the quantification of CA125antigen in serum[J].Clin Chem,1998,44(7):1417-1422.

共引文献30

同被引文献23

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部